Lv7243
5000 积分 2020-12-21 加入
[Expert consensus on PD-L1 expression testing in esophageal carcinoma in China]
10天前
已完结
Cancer statistics, 2023
28天前
已完结
Increased glucose availability sensitizes pancreatic cancer to chemotherapy
28天前
已关闭
Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea
28天前
已完结
Overview and countermeasures of cancer burden in China
28天前
已完结
Pancreatic cancer: Advances and challenges
28天前
已完结
Immune checkpoint inhibitors therapies in patients with cancer and preexisting autoimmune diseases: A meta-analysis of observational studies
2个月前
已完结
Efficacy and safety of gemcitabine/nab-paclitaxel combined with anlotinib and PD-1 inhibitors as a first-line treatment for advanced pancreatic cancer
2个月前
已完结
皖公网安备34019202002308
